Article: Digital transformation is a must - how digitalization will change CDMOs

Benedikt von Braunmühl, our Chief Executive Officer, has contributed to the March 2024 issue of “Plattform Life Sciences” magazine with insights on how the ever-increasing pace of technology, digitalization and automation will change contract development and manufacturing organizations (CDMOs).

Digital transformation is a must for CDMOs, says Benedikt von Braunmühl. In his article he discusses how the "digital revolution 4.0" will change CDMOs in the years to come. Discover the challenges faced by the industry and the invaluable opportunities that arise from embracing digitalization. Additionally, gain insights into the emergence of new professions in the biopharmaceutical sector as a result of this transition.

The complete article "Digital transformation is a must - how digitalization will change CDMOs" can be found here (German language):

To the article


Rentschler Biopharma news Latika Bhonsle-Deeng

Corporate Spokesperson

Rentschler Biopharma SE

Dr. Latika Bhonsle-Deeng
Head of Communications

Get in touch